Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks like bottom play with 34M float !!!
Thanks for the “technical” analysis LOL
Would't touch this above 0.50 cents.
Entry at 0.05 would be ideal.
GOOD EVENING RADAR
happy new year to you & family & all have ah great wkend
* * $AIKI Video Chart 12-31-2020 * *
Link to Video - click here to watch the technical chart video
AIKI...$1.20...in the P/M...:party:
[5:05 AM]
georgie1810/28/2020
AIKI...58...Anthony Hayes, CEO of AIkido stated, "These are the results we have been hoping for and they greatly increase my optimism about the scalability of this product. We plan to rapidly develop the process of drug incorporation into the SLN delivery particles and start preliminary biological testing, which should begin this quarter.":party:
Nice day here not sure what driving the price up?
i thought about that but did not think selling would make a stock go up. please explain if u can, thanks.
People are selling their tax losses causing stocks to go skyrocketing
What is driving the price up?....is there news?
1.18 I sold to soon
I'm looking for the same pump that we got last night into today from BNGO
I just sold. Been holding for way too long
Short squeeze should send a pretty high
I just have a feeling lol
Why you think that
AIKI$ $3 TARGET PRICE WOOHOOOOOOOOOOOOOOO
$aiki $0.5827 v -0.0224 (-3.70%)
Volume: 1,095,172 @12/22/20 6:47:04 PM EST
very healthy climb on the chart.
Alkido Pharma Inc (AIKI)
0.621706 ? -0.010294 (-1.63%)
Volume: 1,598,787 @12/07/20 1:13:36 PM EST
Bid Ask Day's Range
0.6198 0.6219 0.6088 - 0.6527
AIKI Detailed Quote
Alkido Pharma Inc (AIKI)
0.621706 ? -0.010294 (-1.63%)
Volume: 1,598,787 @12/07/20 1:13:36 PM EST
Bid Ask Day's Range
0.6198 0.6219 0.6088 - 0.6527
AIKI Detailed Quote
$aiki $0.5189 ^ 0.0095 (1.86%)
Volume: 1,194,474 @11/25/20 5:53:27 PM EST
Who is picking more at the bottom of 50 cents
$aiki $0.538 ^ 0.0299 (5.88%)
Volume: 1,385,069 @11/13/20 4:20:09 PM EST
Does this garbage scam ticker AIKI have to do a reverse split almost every year so it can stay on the NASDAQ?
Great news! We will see the $0.6's today.
Good morning all! Is something brewing here?
$aiki $0.5225 v -0.0115 (-2.15%)
Volume: 668,799 @11/10/20 4:17:06 PM EST
$aiki $0.5032 v -0.0217 (-4.13%)
Volume: 961,225 @10/30/20 7:56:27 PM EDT
Yep I guess Reverse Split is happening fml all good it was a good trade
very disappointed wit mgmt
Let it ride or
Why didn’t you sell going south, peasants
$AIKI Note: Reverse Split vote Nov. 17
Proxy Statement (definitive) (def 14a)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159175042
TOMORROW. SHE'LL FLY. NO GET RICH QUICK FOLKS ON THIS BOARD...LOL
Followers
|
156
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
8287
|
Created
|
12/30/04
|
Type
|
Free
|
Moderators |
Kucera Paper Lipid Nucleoside Conjugates for the Treatment of Cancer
Kucers & Pardee Paper Improving Nucleoside Analogs via Lipid Conjugation
The Phospholipid Gemcitabine Conjugate, KPC34, is a Novel Treatment for Leukemia
Short-term Toxicity Study of DHA-dFdC
AIkido Pharma Inc. seeks to enhance shareholder value not only through exceptional business performance and practices,
but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual
and institutional investor includes stock price and history, upcoming events and presentations and financial documents.
AIkido Pharma Inc. is traded on the Nasdaq under the ticker symbol AIKI.
AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics.
The Spherix platform contains patented technology from leading universities and researchers and we seek to develop
our innovative drugs through strong partnership with world renowned institutions, such as The University of Texas and Wake Forest University.
Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).
Our pancreatic treatment has shown positive preclinical results for inhibiting pancreatic tumor growth in clinically relevant transgenic mouse models.
The drug has also demonstrated the potential to overcome tumor cell resistance to current chemotherapeutic drugs.
Our AML drug is a next generation targeted therapeutic designed to overcome multiple resistance mechanisms observed with the current standard of care.
In addition, we are constantly seeking to grow our pipe to treat unmet medical needs in oncology.
https://ir.aikidopharma.com/stock-information/
$AIKI Spherix Incorporated, a biotechnology company,focuses on developing small-molecule anti-cancer therapeutics.
Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.
The company's platform consists of patented technology from leading universities and researchers and in the process of developing an
innovative therapeutic drug platform through partnerships with world renowned educational institutions, including The University of Texas at
Austin and Wake Forest University.
It has a scientific research agreement with The University of Texas Southwestern Medical Center to use machine learning to find genetic
markers in people that indicate an increased risk of developing pancreatic cancer.
Spherix Incorporated was founded in 1967 and is based in New York, New York.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |